Kim Kelderman - May 25, 2021 Form 4 Insider Report for BIO-TECHNE Corp (TECH)

Role
Pres. Diagnostics & Genom
Signature
/s/ Brenda S. Furlow as Attorney-in-Fact for Kim Kelderman pursuant to Power of Attorney previously filed.
Stock symbol
TECH
Transactions as of
May 25, 2021
Transactions value $
-$358,280
Form type
4
Date filed
5/27/2021, 04:26 PM
Next filing
Jun 11, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TECH Common Stock Sale -$358K -845 -51.03% $424.00* 811 May 25, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding TECH Stock Options (Right to Buy) 2.65K May 25, 2021 Common Stock 2.65K $150.78 Direct F1
holding TECH Stock Options (Right to Buy) 7.35K May 25, 2021 Common Stock 7.35K $150.78 Direct F2
holding TECH Restricted Stock Units 1.69K May 25, 2021 Common Stock 1.69K Direct F3, F4
holding TECH Stock Options (Right to Buy) 12K May 25, 2021 Common Stock 12K $177.32 Direct F5
holding TECH Stock Options (Right to Buy) 9.03K May 25, 2021 Common Stock 9.03K $177.32 Direct F4
holding TECH Restricted Stock Units 2.36K May 25, 2021 Common Stock 2.36K Direct F3, F6
holding TECH Stock Options (Right to Buy) 12K May 25, 2021 Common Stock 12K $190.41 Direct F6
holding TECH Stock Options (Right to Buy) 15.9K May 25, 2021 Common Stock 15.9K $190.41 Direct F7
holding TECH Restricted Stock Units 2.02K May 25, 2021 Common Stock 2.02K Direct F3, F8
holding TECH Stock Options (Right to Buy) 8.99K May 25, 2021 Common Stock 8.99K $267.87 Direct F8
holding TECH Stock Options (Right to Buy) 12K May 25, 2021 Common Stock 12K $267.87 Direct F9
holding TECH Stock Options (Right to Buy) 8.33K May 25, 2021 Common Stock 8.33K $267.87 Direct F10
holding TECH Stock Options (Right to Buy) 8.33K May 25, 2021 Common Stock 8.33K $267.87 Direct F11
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Options to purchase 663 shares vest on each of 5/1/2019, 5/1/2020, 5/1/2021 and 5/1/2022.
F2 Options to purchase 1,837 shares vest on each of 5/1/2019, 5/1/2020, 5/1/2021 and 5/1/2022.
F3 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
F4 Vests in full or in part on 8/8/2021 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F5 Options to purchase 3,011 shares vest on each of 8/8/2019, 8/8/2020, 8/8/2021 and 8/8/2022.
F6 Vests in full or in part on 8/7/2022 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F7 Options to purchase 3,987 shares vest on each of 8/7/2020, 8/7/2021, 8/7/2022 and 8/7/2023.
F8 Vests in full or in part on 8/5/2023 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F9 Options to purchase 2,997 shares vest on each of 8/5/2021, 8/5/2022, 8/5/2023 and 8/5/2024.
F10 Options to purchase 2,775 shares vest on each of 8/5/2021, 8/5/2022 and 8/5/2023.
F11 Vests in full on the date performance of certain product revenue goals during the period of fiscal 2021-2023 is certified by the Administrator, in no event earlier than 8/5/2021.